Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome.
View Top Employees from Confluence Pharmaceuticals LLC| Website | http://www.confluencepharma.com |
| Revenue | $3 million |
| Employees | 4 (2 on RocketReach) |
| Founded | 2010 |
| Address | 4904 Deer Ridge Dr S, Carmel, Indiana 46033, US |
| Phone | (317) 379-7498 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+7 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Pharmaceutical, Health Care, Therapeutics |
| Web Rank | 24 Million |
| Competitors | Alkermes, Marinus Pharma, OCALI, Parent To Parent Of Georgia, VitaCyte |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Confluence Pharmaceuticals LLC employee's phone or email?
Confluence Pharmaceuticals LLC Questions
The Confluence Pharmaceuticals LLC annual revenue was $3 million in 2024.
Steve Johns is the President and Founder of Confluence Pharmaceuticals LLC.
2 people are employed at Confluence Pharmaceuticals LLC.
Confluence Pharmaceuticals LLC is based in Carmel, Indiana.
The NAICS codes for Confluence Pharmaceuticals LLC are [32541, 32, 3254, 325].
The SIC codes for Confluence Pharmaceuticals LLC are [283, 28].
Top Confluence Pharmaceuticals LLC Employees
-
12
-
24
Related Companies
